Audit 368445

FY End
2024-12-31
Total Expended
$3.95M
Findings
0
Programs
5
Organization: Texas Heart Institute (TX)
Year: 2024 Accepted: 2025-09-29

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $415,148 Yes 0
93.837 Cardiovascular Diseases Research $222,079 Yes 0
12.420 Military Medical Research and Development $205,977 Yes 0
43.007 Space Operations $37,546 Yes 0
93.839 Blood Diseases and Resources Research $9,240 Yes 0

Contacts

Name Title Type
ET52YPHJ2JR3 Darin Maxwell Auditee
8323553653 Laurie Hill Gutierrez Auditor
No contacts on file

Notes to SEFA

Basis of presentation – The schedule of expenditures of federal awards is prepared on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U. S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Federal expenditures include allowable costs funded by federal grants. Allowable costs are subject to the cost principles of the Uniform Guidance and include both costs that are capitalized and costs that are recognized as expenses in the Institute’s financial statements in conformity with generally accepted accounting principles. The Institute does not utilize the 10% de minimus indirect rate, but uses a rate equal to or less than the indirect rate approved by the U. S. Department of Health and Human Services. Because the schedule presents only a selected portion of the operations of THI, it is not intended to and does not present the financial position, changes in net assets, or cash flows of THI.